Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 31, 2001 - Issue 4
121
Views
51
CrossRef citations to date
0
Altmetric
Research Article

Different expression of hepatic and renal cytochrome P450s between the streptozotocininduced diabetic mouse and rat

, , , &
Pages 223-237 | Published online: 22 Sep 2008

References

  • BARCLAY, T. B., PETERS, J. M., SEWER, M. B., FERRARI, L., GONZALEZ, F. J. and MORGAN, E. T., 1999, Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-a dependent. Journal of Pharmacology and Experimental Therapeutics, 290, 1250–1257.
  • BARNETT, C. R., ABBOTT, R. A., BAILEY, C. J., FLATT, P. R. and IOANNIDES, C., 1992b, Cytochrome P450-dependent mixed-function oxidase and glutathione S-transferase activities in spontaneous obesity-diabetes. Biochemical Pharmacology, 43, 1868–1871.
  • BARNETT, C. R., FLATT, P. R. and IOANNIDES, C., 1988, Role of ketone bodies in the diabetes-induced changes in hepatic mixed-function oxidase activities. Biochi mica Biophysica Acta, 967, 250-254. BARNETT, C. R., FLATT, P. R. and IOANNIDES, C., 1990a, Induction of hepatic microsomal P450 I and JIB proteins by hyperketonaemia. Biochemical Pharmacology, 40, 393–397.
  • BARNETT, C. R., GIBSON, G. G., WOLF, C. R., FLATT, P. R. and IOANNIDES, C., 1990b, Induction of cytochrome P450III and P450IV family proteins in streptozotocin-induced diabetes. Biochemical Journal, 268, 765–769.
  • BARNETT, C. R., PETRIDES, L., WILSON, J., FLATT, P. R. and IOANNIDES, C., 1992a, Induction of rat hepatic mixed-function oxidases by acetone and other physiological ketones: their role in diabetes-induced changes in cytochrome P450 proteins. Xenobiotica, 22, 1441–1450.
  • BARNETT, C. R., RUDD, S., FLATT, P. R. and IOANNIDES, C., 1993, Sex differences in the diabetes-induced modulation of rat hepatic cytochrome P450 proteins. Biochemical Pharmacology, 45, 313–319.
  • BELL, D. R., PLANT, N. J., RIDER, C. G., NA, L., BROWN, S., ATEITALLA, I., ACHARYA, S. K., DAVIES, M. H., ELLas, E., JENKINS, N. A., GILBERT, D. J., COPELAND, N. G. and ELCOMBE, C. R., 1993, Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4A cDNAs. Biochemical Journal, 294, 173–180.
  • BELLWARD, G. D., CHANG, T., RODRIGUES, B., McNEILL, J. H., MAINES, S., RYAN, D. E., LEVIN, W. and THOMAS, P. E., 1988, Hepatic cytochrome P450j induction in the spontaneously diabetic BB rat. Molecular Pharmacology, 33, 140–143.
  • BRADFORD, M. M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248–254.
  • CI-EN, T.-L., CI-EN, S.-H., TAI, T.-Y., Co, C.-C., PARK, S. S., GUENGERICH, P. F. and UENG, T.-H., 1996, Induction and suppression of renal and hepatic cytochrome P450-dependent monooxygenases by acute and chronic streptozotocin diabetes in hamsters. Archives in Toxicology, 70, 202–208.
  • CHOMCZYNSKI, P. and SACCHI, N., 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol- chloroform extraction. Analytical Biochemistry, 162, 156–159.
  • DONG, Z., HONG, J., MA, Q., Li, D., BULLOCK, J., GONZALEZ, F. J., PAR-I, S. S., GELBOIN, H. V. and YANG, C. S., 1988, Mechanism of induction of cytochrome P450ac (P450j) in chemically induced and spontaneously diabetic rats. Archives in Biochemistry and Biophysics, 263, 29–35.
  • FAVREAU, L. V. and SCHENKMAN, J. B., 1988a, Composition changes in hepatic microsomal cytochrome P-450 during onset of streptozocin-induced diabetes and during insulin treatment. Diabetes, 37, 577–584.
  • FAVREAU, L. V. and SCHENKMAN, J. B., 1988b, Cytochrome P-450 alterations in the BB/Wor spontaneously diabetic rat. Biochemical Pharmacology, 37, 3505–3509.
  • FORMAN, B. M., CI-EN, J. M. and EVANS, R. M., 1997, Hypolipidemic drugs polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors a and -y. Proceedings of the National Academy of Sciences, USA, 94, 4312–4317.
  • GOTTLICHER, M., WIDMARK, E., Li, Q. and GUSTAFSSON, J.-A, 1992, Fatty acid activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proceedings of the National Academy of Sciences, USA, 89, 4653–4657.
  • GUENGERICH, P. F., 1991, Reactions and significance of cytochrome P-450 enzymes. Journal of Biological Chemistry, 266, 10019–10022.
  • HENDERSON, C. J., BAMMLER, T. and WOLF, C. R., 1994, Deduced amino acid sequence of a murine cytochrome P-450 Cyp4a protein: developmental and hormonal regulation in liver and kidney. Biochimica et Biophysica Ada, 1200, 182–190.
  • HENG, Y. M., SHARON Kuo, C.-W., Jos, P. S., SAVORY, R., SCHULZ, R. M., TOMLINSON, S. R., GRAY, T. J. B. and BELL, D. R., 1997, A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans. Biochemical Journal, 325, 741–749.
  • HONG, J. -Y., NING, S. M., MA, B.-L., LEE, M.-J., PAN, J. and YANG, C. S., 1990, Role of pituitary hormones in the regulation of hepatic cytochrome P45011E1 in rats and mice. Archives of Biochemistry and Biophysics, 281, 132–138.
  • IOANNIDES, C., BARNETT, C. R., IRIZAR, A. and FLATT, P. R., 1996, Expression of cytochrome P450 proteins in disease. In C. Ioannides (ed.), Cytochrome P450: Metabolic and Toxicological Aspects (Boca Raton: CRC Press), pp. 301–327.
  • JARUKAMJORN, K., SAKUMA, T., MIYAURA, J. and NEMOTO, N., 1999, Different regulation of the expression of mouse hepatic cytochrome P450 2B enzymes by glucocorticoid and phenobarbital. Archives of Biochemistry and Biophysics, 369, 89–99.
  • KAMATAKI, T. and KITAGAWA, H., 1974, Effects of lyophilization and storage of rat liver microsomes on activity of aniline hydroxylase, contents of cytochrome b5 and cytochrome P-450 and aniline-induced P-450 difference spectrum. Japanese Journal of Pharmacology, 24, 195–203.
  • KIMURA, S., HARDWICK, J. P., KOZAK, C. A. and GONZALEZ F, J., 1989, The rat clofibrate-inducible CYP4A subfamily. II. cDNA sequence of IVA3, mapping of the Cyp4a locus to mouse chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes. DNA, 8, 517–525.
  • KNODELL, R. G., HANDWERGER, B. S., MORLEY, J. E., LEVINE, A. S. and BROWN, D. M., 1984, Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus. Journal of Pharmacology and Experimental Therapeutics, 230, 256–262.
  • KROETZ, D. L., YooK, P., COSTET, P., BIANCHI, P. and PINEAU. T., 1998, Peroxisome proliferator-activated receptor a controls the hepatic CYP4A induction adaptive response to starvation and diabetes. Journal of Biological Chemistry, 273, 31581–31589.
  • MURAO, S., SATO, M., TAMAKI, M., NIIMI, M., ISHIDA, T. and TAKAHARA, J., 1995, Suppression of episodic growth hormone secretion in the streptozotocin-induced diabetic mouse: time-course studies on the hypothalamic pituitary axis. Endocrinology, 136, 4498–4504.
  • NASH, T., 1953, The colormetric estimation of formaldehyde by means of the Hantzsch reaction. Biochemical Journal, 55, 416–421.
  • NEMOTO, N. and SAKURAI, J., 1993, Activation of Cyplal and Cypla2 genes in adult mouse hepatocytes in primary culture. Japanese Journal of Cancer Research, 84, 272–278.
  • NEMOTO, N., SAKURAI, J. and FUNAE, Y., 1995, Maintenance of phenobarbital-inducible Cyp2b gene expression in C57BL/6 mouse hepatocytes in primary culture as spheroids. Archives of Biochemistry and Biophysics, 316, 362–369.
  • NEMOTO, N., SAKURAI, J., TAZAWA, A. and IsmKAwA, T., 1989, Proline-dependent expression of aryl hydrocarbon hydroxylase in C57BL/6 mouse hepatocytes in primary culture. Cancer Research, 49, 5863–5869.
  • OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its haemoprotein nature. Journal of Biological Chemistry, 239, 2370–2378.
  • PARK, S.-H., Liu, X., HENNIGHAUSEN, L., DAVEY, H. W. and WAXMAN, D. J., 1999, Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression: Impact of Stat5a gene disruption. Journal of Biological Chemistry, 274, 7421–7430.
  • PHILLIFS, A. H. and LANGDON, R. G., 1962, Hepatic triphosphopyridine nucleotide cytochrome c reductase: isolation, characterization, and kinetic studies. Journal of Biological Chemistry, 237, 2652–2660.
  • PORTER, T. D. and COON, M. J., 1991, Cytochrome P-450: multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. Journal of Biological Chemistry, 266, 13469–13472.
  • SAKUMA, T., OH-TAKE, M., KATSURAYAMA, Y., JARUKAMJORN, K. and NEMOTO, N., 1999, Induction of CYP1A2 by phenobarbital in the livers of aryl hydrocarbon-responsive and -nonresponsive mice. Drug Metabolism and Disposition, 27, 379–384.
  • SAKUMA, T., TAI, M., ENDO, Y., KuRorwA, M., OHARA, A., JARUKAMJORN, K., HONMA, R. and NEMOTO, N., 2000, A novel female-specific member of the CYP3A gene subfamily in the mouse liver. Archives of Biochemistry and Biophysics, 377, 153–162.
  • SCHENKMAN, J. B., REMMER, H. and ESTABROOK, R. W., 1967, Spectral studies of drug interaction with hepatic microsomal cytochrome. Molecular Pharmacology, 3, 113–123.
  • SCHENKMAN, J. B., THUMMEL, K. E. and FAVREAU, L. V., 1989, Physiological and pathophysiological alterations in rat hepatic cytochrome P-450. Drug Metabolism Reviews, 20, 557–584.
  • SCHMIDT, F. H., 1961, Die enzymatische Bestirnmung von Glucose und Fructose nebeneinander. Klinische Wochenschrift, 39, 1244–1247.
  • Smmojo, N., 1994, Cytochrome P450 changes in rats with streptozocin-induced diabetes. International Journal of Biochemistry, 26, 1261–1268.
  • Smmojo, N., Isorzmu, T., ImAoRA, S., FUN, Y., Fujii, S. and OKUDA, K., 1993, Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozotocin-induced diabetes. Biochemical Pharmacology, 46, 621–627.
  • TIRIMMEL, K. E. and SCHENKMAN, J. B., 1990, Effects of testosterone and growth hormone treatment on hepatic microsomal P450 expression in the diabetic rat. Molecular Pharmacology, 37, 119–129.
  • WAXMAN, D. J., RAM, P. A., PARK, S. H. and Com, H. K., 1995, Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription. Journal of Biological Chemistry, 270, 13262–13270.
  • YAMAZOE, Y., ABUZEID, M., YAMAUCIII, K., MURAYAMA, N., SHIMADA, M. and KATO, R., 1988, Enhancement by alloxan-diabetes of the rate of metabolic activation of three pyrolysate carcinogens via increase in the P-448-H content in rat liver. Biochemical Pharmacology, 37, 2503–2506.
  • YAMAZOE, Y., LING, X., MURAYAMA, N., GONG, D., NAGATA, K. and KATO, R., 1990, Modulation of hepatic level of microsomal testosterone 7a-hydroxylase, P-450a (P450IIA), by thyroid hormone and growth hormone in rat liver. Journal of Biochemistry, 108, 599–603.
  • YAMAZOE, Y., MURAYAMA, N., SHIMADA, M., ImAoRA, S., FUNAE, Y. and KATO, R., 1989a, Suppression of hepatic levels of an ethanol-inducible P450DM/j by growth hormone: relationship between the increased level of P450DM/j and depletion of growth hormone in diabetes. Molecular Pharmacology, 36, 716–722.
  • YAMAZOE, Y., MURAYAMA, N., SHIMADA, M., YAMAUCIII, K. and KAYO, R., 1989b, Cytochrome P-450 in livers of diabetic rats: regulation by growth hormone and insulin. Archives of Biochemistry and Biophysics, 268, 567–575.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.